Cell-free Tumor DNA in Head and Neck Cancer Patients
NCT03942380 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500
Last updated 2021-09-21
Summary
This study investigates if head and neck squamous cell carcinoma can be tracked with cell-free tumor DNA, RNA or HPV-DNA, in blood samples from patients referred with suspicion of cancer, and if it can be used in detecting recurrence in patients already diagnosed and treated for head and neck squamous cell carcinoma.
Conditions
- Head and Neck Cancer
- Head and Neck Neoplasms
- Head and Neck Squamous Cell Carcinoma
- Oropharynx Cancer
- Oropharynx Neoplasm
- Oropharynx Carcinoma
- Oral Cavity Cancer
- Oral Cancer
- Oral Neoplasm
- Larynx Cancer
- Larynx Carcinoma
- Larynx Neoplasm
- Nasopharyngeal Carcinoma
- Nasopharyngeal Cancer
- Nasopharynx Neoplasm
- Hypopharynx Cancer
- Hypopharynx Neoplasm
- Hypopharynx Carcinoma
- Sinonasal Carcinoma
- Thyroid Carcinoma
- Thyroid Cancer
- Thyroid Neoplasms
- Salivary Gland Cancer
- Salivary Gland Neoplasms
- Salivary Gland Carcinoma
- Sinonasal Cancer
- Sinonasal Neoplasm
Interventions
- DIAGNOSTIC_TEST
-
Liquid biopsy
The intervention is a liquid biopsy as a blood sample taken in a peripheral vein. The blood samples are analyzed for cell free DNA, RNA and HPV-DNA
Sponsors & Collaborators
-
Copenhagen University Hospital, Denmark
collaborator OTHER -
Department of Otorhinolaryngology, Head and Neck Surgery and Audiology
collaborator UNKNOWN -
Christian von Buchwald
lead OTHER
Principal Investigators
-
Christian Von Buchwald, MD, DMSc · Department of Otorhinolaryngology, Head and Neck Surgery and Audiology
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- SINGLE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-02-01
- Primary Completion
- 2025-02-01
- Completion
- 2025-02-01
Countries
- Denmark
Study Locations
More Related Trials
-
Anti-tumor Specific Immune Response in Head and Neck Cancers
NCT02881918 ·Status: UNKNOWN
-
Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study
NCT04900623 ·Status: RECRUITING ·Phase: PHASE2
-
De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study
NCT02281955 ·Status: COMPLETED ·Phase: PHASE2
-
Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers
NCT05582590 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy
NCT04920344 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)
NCT01312350 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration in HPV+ Head and Neck Cancer of Unknown Primaries
NCT04489212 ·Status: COMPLETED ·Phase: NA
-
Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
NCT01358097 ·Status: COMPLETED
-
Observational Study on Biomarkers in Head and Neck Cancer (HNprädBio)
NCT02059668 ·Status: COMPLETED
-
Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer
NCT06445114 ·Status: RECRUITING ·Phase: PHASE2
-
Studying Survivorship Care Plans in Head and Neck Cancer
NCT03106090 ·Status: TERMINATED ·Phase: NA
-
ctHPVDNA in HPV Positive Squamous Cell Carcinoma of the Oropharynx
NCT06915038 ·Status: RECRUITING ·Phase: NA
-
Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma
NCT05845632 ·Status: UNKNOWN
-
Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral Cavity
NCT01525927 ·Status: TERMINATED ·Phase: PHASE2
-
Identification of Predictive Factors for the Response to Anti-Programmed Cell Death Protein 1 (PD1) Immunotherapy in Head and Neck Squamous Cell Carcinoma
NCT05328024 ·Status: RECRUITING
-
De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcinomas
NCT03396718 ·Status: RECRUITING ·Phase: NA
-
First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients
NCT04858269 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Immunologic Responses in HPV-Associated Carcinoma for Patients Receiving Chemoradiation
NCT01958515 ·Status: COMPLETED
-
HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma
NCT05962242 ·Status: RECRUITING ·Phase: PHASE2
-
Phase II Trial: uPAR-PET/CT for Prognostication in Head- and Neck Cancer
NCT02965001 ·Status: COMPLETED ·Phase: PHASE2
-
S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer
NCT00095641 ·Status: WITHDRAWN ·Phase: PHASE2
-
C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT00402545 ·Status: COMPLETED ·Phase: PHASE1
-
Analysis of Patterns of Recurrence in Head and Neck Cancer Using Clinicopathomic Markers
NCT04086849 ·Status: COMPLETED
-
Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer
NCT06223568 ·Status: RECRUITING ·Phase: PHASE2
-
Patient-derived Xenograft Models of Tumor From Patients With Head and Neck Cancer
NCT02572778 ·Status: RECRUITING